Daily non-political popular news in brief.

Soy estrogens and breast cancer: Researcher offers overview

Are soy products healthy additions to a person’s diet, safe alternatives to hormone-replacement therapy or cancer-causing agents? The answer, according to University of Illinois food science and human nutrition professor William Helferich, is, "It depends."

Read more »

Keywords: soy, estrogens, breast, cancer, researcher, offers, overview, estrogen, offer

« Previous | Next »

Similar news on "Soy estrogens and breast cancer: Researcher offers overview":

1. Researchers identify key gene that may be a marker of breast cancer metastasis
   04-18-2007 · EurekAlert!
   Researchers at Fox Chase Cancer Center have identified an important gene involved in the spread of breast cancer that has developed resistance to long-term estrogen deprivation. The gene may prove to be a useful marker for predicting which patients have the greatest risk of breast cancer recurrence so their doctors can offer the most appropriate treatment plan.
   Similar news · Read more »
   
2. Moving beyond tamoxifen: Drug discovery and the future of selective hormone receptor modulators
   02-15-2008 · EurekAlert!
   How did a failed contraceptive become the first targeted therapy for the treatment of breast cancer? The transformation of tamoxifen, from cast-off to lifesaver, laid the foundation for a new class of therapeutics -- selective estrogen receptor modulators. V. Craig Jordan, a researcher at the Fox Chase Cancer Center in Philadelphia, Jordan reports on efforts to use the lessons from tamoxifen to develop new hormone receptor-related drugs for both women and men.
   Similar news · Read more »
   
3. Linchpin gene may be useful target for new breast cancer therapies
   09-15-2007 · EurekAlert!
   University of Iowa researchers have discovered a gene that plays a linchpin role in the ability of breast cancer cells to respond to estrogen. The finding may lead to improved therapies for hormone-responsive breast cancers, and may explain differences in the effectiveness of current treatments.
   Similar news · Read more »
   
4. Ireland Cancer Center researcher finds standard treatment for breast cancer not followed
   12-21-2007 · EurekAlert!
   Research out of the Ireland Cancer Center of University Hospitals Case Medical Center, in collaboration with six integrated health plans that are part of the Cancer Research Network, found that the majority of older women with early stage breast cancer fail to adhere to the standard of treatment -- five years of daily oral use of the chemo-prevention drug Tamoxifen.
   Similar news · Read more »
   
5. Tamoxifen yields long-term reduction in breast cancer risk
   02-20-2007 · EurekAlert!
   Tamoxifen offers long-term benefits for breast cancer prevention among women at high risk of the disease, according to two randomized, blinded clinical trials in the February 21 Journal of the National Cancer Institute. The trials found that the breast cancer risk reduction persists long after women stop taking tamoxifen.
   Similar news · Read more »
   
6. Exceeding '5/day' guide for veggie, fruit intake doesn't reduce chance of breast cancer recurrence
   07-17-2007 · EurekAlert!
   Eating double the amount of veggies and fruits recommended by general dietary guidelines doesn't reduce the likelihood of breast cancer recurrence among women whose cancers were treated at an early stage of the disease, says a researcher at the Stanford University School of Medicine.
   Similar news · Read more »
   
7. Yale study offers insight into possible cause of lymphoma
   02-14-2008 · EurekAlert!
   The immune system's powerful cellular mutation and repair processes appear to offer important clues as to how lymphatic cancer develops, Yale School of Medicine researchers report this week in Nature.
   Similar news · Read more »
   
8. Combined HRT increases risk of lobular breast cancer fourfold after just 3 years of use
   01-15-2008 · EurekAlert!
   Postmenopausal women who take combined estrogen/progestin hormone-replacement therapy for three years or more face a fourfold increased risk of developing various forms of lobular breast cancer, according to new findings by researchers at Fred Hutchinson Cancer Research Center.
   Similar news · Read more »
   
9. Analysis of breast-cancer gene role offers promising target for drugs to stop or slow progression of disease
   10-30-2006 · UT Southwestern Medical Center
   Researchers at UT Southwestern Medical Center have for the first time described how multiple copies of a gene are responsible for metastases in early-stage breast cancer and poor prognosis for patients.
   Similar news · Read more »
   
10. Small molecule offers big hope against cancer
    01-16-2007 · EurekAlert!
    Researchers at the University of Alberta have shown that a nontoxic molecule shrinks cancers tumors, including lung, breast and brain. The results of the research will be published in the journal Cancer Cell.
    Similar news · Read more »